Identification of human herpesvirus 8-specific cytotoxic T-cell responses

被引:86
作者
Osman, M
Kubo, T
Gill, J
Neipel, F
Becker, M
Smith, G
Weiss, R
Gazzard, B
Boshoff, C [1 ]
Gotch, F
机构
[1] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Sch Med, Dept Immunol, London SW10 9NH, England
[2] Univ Erlangen Nurnberg, Inst Klin & Mol Virol, D-91054 Erlangen, Germany
[3] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Sch Med, Dept Genitourinary Med, London SW10 9NH, England
[4] UCL, Royal Free & Univ Coll Med Sch, Dept Oncol, London, England
[5] UCL, Royal Free & Univ Coll Med Sch, Dept Mol Pathol, London, England
[6] Univ Oxford, Dunn Sch Pathol, Oxford, England
基金
英国惠康基金;
关键词
D O I
10.1128/JVI.73.7.6136-6140.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human herpesvirus 8 (HHV-8)(or Kaposi's sarcoma;associated herpesvirus) is implicated in the etiopathogenesis of Kaposi's sarcoma (KS) and certain lymphoproliferations. The introduction of more effective therapies to treat human immunodeficiency virus infection has led to a decline in the incidence of KS and also in the resolution of KS in those already affected, This suggests that cellular immune responses including cytotoxic T lymphocytes (CTLs) could play a vital role in the control of HHV-8 infection and in KS pathogenesis. Here we elucidate HLA class I-restricted, HHV-8-specific cellular immune responses that could be important in the control of HRV-I infection and subsequent tumor development. We show the presence of CTLs against HHV-8 latent (K12), lytic (K8.1), and highly variable (K1) proteins in infected individuals.
引用
收藏
页码:6136 / 6140
页数:5
相关论文
共 35 条
  • [1] Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice
    Boshoff, C
    Gao, SJ
    Healy, LE
    Matthews, S
    Thomas, AJ
    Coignet, L
    Warnke, RA
    Strauchen, JA
    Matutes, E
    Kamel, OW
    Moore, PS
    Weiss, RA
    Chang, Y
    [J]. BLOOD, 1998, 91 (05) : 1671 - 1679
  • [2] Kaposi's sarcoma-associated herpesvirus
    Boshoff, C
    Weiss, RA
    [J]. ADVANCES IN CANCER RESEARCH, VOL 75, 1998, 75 : 57 - 86
  • [3] Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: Propagation and generation of recombinant viruses in a nonhuman mammalian cell line
    Carroll, MW
    Moss, B
    [J]. VIROLOGY, 1997, 238 (02) : 198 - 211
  • [4] The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases
    Cesarman, E
    Knowles, DM
    [J]. SEMINARS IN CANCER BIOLOGY, 1999, 9 (03) : 165 - 174
  • [5] VACCINIA VIRUS EXPRESSION VECTOR - COEXPRESSION OF BETA-GALACTOSIDASE PROVIDES VISUAL SCREENING OF RECOMBINANT VIRUS PLAQUES
    CHAKRABARTI, S
    BRECHLING, K
    MOSS, B
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) : 3403 - 3409
  • [6] IDENTIFICATION OF HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-ASSOCIATED KAPOSIS-SARCOMA
    CHANG, Y
    CESARMAN, E
    PESSIN, MS
    LEE, F
    CULPEPPER, J
    KNOWLES, DM
    MOORE, PS
    [J]. SCIENCE, 1994, 266 (5192) : 1865 - 1869
  • [7] Chang Y, 1996, INFECT AGENT DIS, V5, P215
  • [8] Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma
    Dupin, N
    Fisher, C
    Kellam, P
    Ariad, S
    Tulliez, M
    Franck, N
    van Marck, E
    Salmon, D
    Gorin, I
    Escande, JP
    Weiss, RA
    Alitalo, K
    Boshoff, C
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) : 4546 - 4551
  • [9] EPSTEIN MA, 1986, LANCET, V1, P1425
  • [10] Biomedicine - The enigmas of Kaposi's sarcoma
    Gallo, RC
    [J]. SCIENCE, 1998, 282 (5395) : 1837 - 1839